If you need more lookups,
subscriptions start at $34 USD/month.
Peter Terreri Location
Ambler, PA, US
Peter Terreri Work
2022 -now Board Positions and Advisory @ PRT Advisory and Consulting
2000 -2021 President @ C.G.M., Inc.
2018 -2020 Board Member @
2001 -2018 Board Member @
1981 -2000 Chief Financial Officer @ Teva Pharmaceuticals, USA
Peter Terreri Education
Drexel University - College of Business and Administration
Bachelor of Science (BS) (Accounting)
1975-1980
Peter Terreri Skills
Certified Public Accountant
CPA
SEC filings
Mergers & Acquisitions
Sarbanes-Oxley Act
Auditing
Biotechnology
Financial Reporting
Business Planning
Forensic Accounting
Capital Budgeting
Small Business
Strategic Thinking
Acquisition Integration
Risk Assessment
Financial Modeling
Managed Care
Strategic Planning
Cross-functional Team Leadership
US GAAP
Strategic Financial Planning
Pharmaceutical Industry
Corporate Finance
Fixed Assets
Financial Analysis
Managerial Finance
GAAP
Sarbanes-Oxley
Cost Accounting
Budgets
Start-ups
Valuation
Internal Audit
Reviews
Corporate Tax
Financial Accounting
Payroll
Financial Statements
Tax
Income Tax
Due Diligence
Process Improvement
Forecasting
Private Equity
Executive Management
Tax Accounting
Finance
Accounting
Internal Controls
Start Ups
Sarbanes Oxley
Cross Functional Team Leadership
Sarbanes Oxley Act
Mergers and Acquisitions
Peter Terreri Summary
Peter Terreri, based in Ambler, PA, US, is currently a Board Positions and Advisory at PRT Advisory and Consulting. Peter Terreri brings experience from previous roles at C.G.M., Inc., Amneal Pharmaceuticals, Impax Laboratories and Teva Pharmaceuticals, USA. Peter Terreri holds a 1975 - 1980 Bachelor of Science (BS) in Accounting @ Drexel University - College of Business and Administration. With a robust skill set that includes Certified Public Accountant, CPA, SEC filings, Mergers & Acquisitions, Sarbanes-Oxley Act and more. Peter Terreri has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Peter Terreri?
Find contact details for 700 million professionals.